Baciphelacin: a new eukaryotic translation inhibitor.
Baciphelacin an antibiotic produced by Bacillus thiaminolyticus was a potent inhibitor of protein synthesis in HeLa cells and other mammalian cell lines. It had no effect on DNA or RNA synthesis. Concentrations of baciphelacin around 10(-7) M inhibited protein synthesis by 50% in intact cells. The antibiotic had no effect on protein synthesis in Saccharomyces cerevisiae or Escherichia coli, but inhibited the protozoan Trypanosoma brucei. In vitro protein synthesis in a rabbit reticulocyte cell-free system was blocked by baciphelacin. However, translation of globin mRNA in a wheat cell-free system was not affected by this antibiotic. Baciphelacin had no activity against a number of cell-free systems used to measure different steps of translation, including binding of substrates to the ribosome, peptide bond formation and polyphenylalanine synthesis. Therefore, it is assumed that it affects the initiation of translation or the charging of tRNA. Finally, the inhibition of protein synthesis by compounds structurally related to baciphelacin was tested and their effects compared to baciphelacin.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002474:Cell-Free System; D003374:Coumarins / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D005057:Eukaryotic Cells; D006367:HeLa Cells; D006801:Humans; D049934:Isocoumarins; D014176:Protein Biosynthesis / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D003374:Coumarins; D049934:Isocoumarins; C011173:baciphelacin; D004247:DNA